{"filing":{"accession_number":"0001213900-26-102033","cik":"0001631487","ticker":"CLGN","company_name":"CollPlant Biotechnologies Ltd","form":"6-K","filing_date":"2026-09-22","report_date":"2026-09-22","primary_document":"ea0306194-6k_collplant.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1631487/000121390026102033/ea0306194-6k_collplant.htm"},"events":[{"id":34235,"run_id":31504,"accession_number":"0001213900-26-102033","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"The press release announces that CollPlant has regained compliance with Nasdaq Listing Rule 5550(a)(2) following a deficiency notice received on March 23, 2026 for trading below the $1.00 minimum bid price. The notification confirms the company has satisfied the continued listing requirement and the matter is formally closed. This disclosure directly addresses delisting risk — the resolution of a prior failure to satisfy a continued listing rule, which is material to investors assessing the registrant's exchange listing status.","company_name":"CollPlant Biotechnologies Ltd","ticker":"CLGN","filing_date":"2026-09-22","form":"6-K","submitted_at":null,"items":[{"id":37916,"accession_number":"0001213900-26-102033","item_number":"EX-99.1","item_title":"ea030619401ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The press release announces that CollPlant has regained compliance with Nasdaq Listing Rule 5550(a)(2) following a deficiency notice received on March 23, 2026 for trading below the $1.00 minimum bid price. The notification confirms the company has satisfied the continued listing requirement and the matter is formally closed. This disclosure directly addresses delisting risk — the resolution of a prior failure to satisfy a continued listing rule, which is material to investors assessing the registrant's exchange listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-22T14:41:38.531186+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":37916,"accession_number":"0001213900-26-102033","item_number":"EX-99.1","item_title":"ea030619401ex99-1.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"The press release announces that CollPlant has regained compliance with Nasdaq Listing Rule 5550(a)(2) following a deficiency notice received on March 23, 2026 for trading below the $1.00 minimum bid price. The notification confirms the company has satisfied the continued listing requirement and the matter is formally closed. This disclosure directly addresses delisting risk — the resolution of a prior failure to satisfy a continued listing rule, which is material to investors assessing the registrant's exchange listing status.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-09-22T14:41:38.531186+00:00","company_name":"CollPlant Biotechnologies Ltd","ticker":"CLGN","filing_date":"2026-09-22"}]}